Research Interests
atherosclerosis/thrombosis
,
diabetes
,
genetics/genome
,
osteoporosis
Recent Publications
Sergeant S, Hugenschmidt CE, Rudock ME, Ziegler JT, Ivester P, Ainsworth HC, Vaidya D, Case LD, Langefeld CD, Freedman BI, Bowden DW, Mathias RA, Chilton FH.
Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome. Br J Nutr.
2012;
107(4):547-555.
Ng MCY, Hester JM, Wing MR, Li J, Xu J, Hicks PJ, Roh BH, Lu L, Divers J, Langefeld CD, Freedman BI, Palmer ND, Bowden DW.
Genome-wide association of BMI in African Americans. Obesity (Silver Spring).
2012;
20(3):622-627.
Rao M, Mottl AK, Cole SA, Umans JG, Freedman BI, Bowden DW, Langefeld CD, Fox CS, Yang Q, Cupples A, Iyengar SK, Hunt SC, Trikalinos TA.
Meta-analysis of genome-wide linkage scans for renal function traits. Nephrol Dial Transplant.
2012;
27(2):647-656.
Palmer ND, McDonough CW, Hicks PJ, Roh BH, Wing MR, An SS, Hester JM, Cooke JN, Bostrom MA, Rudock ME, Talbert ME, Lewis JP, Lu L, Ziegler JT, Divers J, Ng MCY, Langefeld CD, Freedman BI, Bowden DW, et al.
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS ONE.
2012;
7(1):e29202.
Bostrom MA, Kao WHL, Li M, Abboud HE, Adler SG, Iyengar SK, Kimmel PL, Hanson RL, Nicholas SB, Rasooly RS, Lu L, Hicks PJ, Langefeld CD, Bowden DW, Freedman BI, et al.
Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy. Am J Kidney Dis.
2012;
59(2):210-221.
Hester JM, Wing MR, Li J, Palmer ND, Xu J, Hicks PJ, Roh BH, Norris JM, Wagenknecht LE, Langefeld CD, Freedman BI, Bowden DW, Ng MCY.
Implication of European-derived adiposity loci in African Americans. Int J Obes (Lond).
2012;
36(3):465-473.
Freedman BI, Bowden DW, Rich SS.
Genetic basis of kidney disease. In: Taal MW, Chertow GM, Marsden PA, Skorecki K, Yu ASL, Brenner BM, eds. Brenner & Rector's the kidney, vol 2. 9th ed.
Philadelphia: Elsevier Saunders;
2012:
1554-1569.
Lin CP, Adrianto I, Lessard CJ, Kelly JA, Kaufman KM, Guthridge JM, Freedman BI, Anaya J-M, Alarcon-Riquelme ME, Pons-Estel BA, Martin J, Glenn S, Adler A, Bae S-C, Park S-Y, Bang S-Y, Song Y-W, Boackle SA, Brown EE, Edberg JC,.
Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun.
2012;
13(3):232-238.
McDonough CW, Palmer ND, Hicks PJ, Roh BH, An SS, Cooke JN, Hester JM, Wing MR, Bostrom MA, Rudock ME, Lewis JP, Talbert ME, Blevins RA, Lu L, Ng MCY, Divers J, Langefeld CD, Freedman BI, Bowden DW, et al.
A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int.
2011;
79(5):563-572.
Lessard CJ, Adrianto I, Kelly JA, Kaufman KM, Grundahl KM, Adler A, Williams AH, Gallant CJ, Freedman BI, Langefeld CD, et al.
Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. Am J Hum Genet.
2011;
88(1):83-91.
Adrianto I, Wen F, Templeton A, Wiley G, King JB, Lessard CJ, Bates JS, Hu Y, Freedman BI, Langefeld CD, et al.
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet.
2011;
43(3):253-258.
Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin J-J, Kiger DF, Gautreaux MD, Divers J, Freedman BI.
The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant.
2011;
11(5):1025-1030.
Freedman BI, Langefeld CD, Lu L, Divers J, Comeau ME, Palmer ND, Hicks PJ, Bostrom MA, Cooke JN, McDonough CW, Bowden DW, et al.
Differential effects of MYH9 and APOL1 risk variants on FRMD3 association with diabetic ESRD in African Americans. PLoS Genet.
2011;
7(6):e1002150.
Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A, Alarcon-Riquelme ME, Perrino FW, Freedman BI, Langefeld CD, et al.
Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun.
2011;
12(4):270-279.
Mathias RA, Sergeant S, Hugenschmidt CE, Ziegler JT, Ivester P, Case D, Freedman BI, Rudock ME, Langefeld CD, Bowden DW, Chilton FH, et al.
The impact of FADS genetic variants on omega-6 polyunsaturated fatty acid metabolism in African Americans. BMC Genet.
2011;
12():article 50.
Zhao J, Wu H, Khosravi M, Cui H, Langefeld CD, Williams AH, Comeau ME, Ziegler JT, Marion MC, Freedman BI, et al.
Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet.
2011;
7(5):e1002079.
Tan W, Zhao J, Deng Y, Kaufman K, Kelly J, Bae S, Chang D, Yu C, Kimberly R, Freedman B, et al.
Association of PPP2CA polymorphisms with SLE susceptibility in multiple ethnic groups [abstract]. Intern Med J.
2011;
41(Suppl 1):1.
Igo RP Jr, Iyengar SK, Nicholas SB, Goddard KAB, Langefeld CD, Hanson RL, Duggirala R, Divers J, Bowden DW, Freedman BI, et al.
Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study. Am J Nephrol.
2011;
33(5):381-389.
Freedman BI, Andries L, Shihabi ZK, Rocco MV, Byers JR, Cardona CY, Graham AD, Mauck VL, Russell GB, Bleyer AJ, et al.
Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. Clin J Am Soc Nephrol.
2011;
6(7):1635-1643.
Irvin MR, Wineinger NE, Rice TK, Pajewski NM, Kabagambe EK, Gu CC, Pankow J, North KE, Wilk JB, Freedman BI, et al.
Genome-wide detection of allele specific copy number variation associated with insulin resistance in African Americans from the HyperGEN Study. PLoS ONE.
2011;
6(8):e24052.
Ma L, Mondal AK, Murea M, Sharma NK, Langberg KA, Das SK, Antinozzi PA, Parks JS, Elbein SC [deceased], Freedman BI, et al.
The effect of ACACB cis-variants on gene expression and metabolic traits. PLoS ONE.
2011;
6(8):e23860.
Sanchez E, Nadig A, Richardson BC, Freedman BI, Kaufman KM, Kelly JA, Niewold TB, Kamen DL, Ziegler JT, Langefeld CD, et al.
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis.
2011;
70(10):1752-1757.
Reeves-Daniel A, Bailey A, Assimos D, Westcott C, Adams PL, Hartmann EL, Rogers J, Farney AC, Stratta RJ, Daniel K, Freedman BI.
Donor-recipient relationships in African American vs. Caucasian live kidney donors. Clin Transplant.
2011;
25(5):E487-E490.
Tan W, Sunahori K, Zhao J, Deng Y, Langefeld CD, Williams AH, Comeau ME, Ziegler JT, Marion MC, Freedman BI, et al.
Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. Arthritis Rheum.
2011;
63(9):2755-2763.
Murea M, Register TC, Divers J, Bowden DW, Carr JJ, Hightower RC, Smith SC, Hruska KA, Langefeld CD, Freedman BI.
Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study [abstract]. J Am Soc Nephrol.
2011;
22(Abstract Suppl):715A.
Freedman BI, Langefeld CD, Murea M, Ma L, Otvos JD, Turner J, Antinozzi PA, Rocco MV, Parks JS.
Apolipoprotein L1 (APOL1) nephropathy risk variants associate with HDL subfraction concentration in African Americans [abstract]. J Am Soc Nephrol.
2011;
22(Abstract Suppl):178A.
Freedman BI, Hicks PJ, Langefeld CD, Lu L, Bleyer AJ, Divers J, Nachman PH, Derebail VK, Bowden DW.
Sickle cell trait is not associated with ESRD susceptibility in African Americans [abstract]. J Am Soc Nephrol.
2011;
22(Abstract Suppl):463A.
Winkler CA, Freedman BI, Kao WHL, Langefeld CD, Astor BC, Nelson GW, Comeau ME, Bowden DW, Kopp JB, Lipkowitz MS.
APOL1 risk genotypes are enriched in African American Study of Kidney Disease and Hypertension (AASK) participants, particularly among those with kidney disease progression [abstract]. J Am Soc Nephrol.
2011;
22(Abstract Suppl):458A-459A.
Kopp JB, Freedman BI, Winkler CA, Nelson GW, Bowden DW, Comeau ME, Langefeld CD.
APOL1 and MYH9 genetic variants are independently associated with kidney disease risk in African Americans [abstract]. J Am Soc Nephrol.
2011;
22(Abstract Suppl):460A-461A.
Cox AJ, Lehtinen AB, Xu J, Langefeld CD, Freedman BI, Carr JJ, Bowden DW.
Polymorphisms in the selenoprotein S gene are associated with quantitative measures of subclinical cardiovascular disease in the Diabetes Heart Study [abstract]. Diabetes.
2011;
60(Suppl 1):A5.
Hugenschmidt C, Hayasaka S, Langefeld C, Freedman B, Carr JJ, Williamson J, Bowden DW.
Cognitive performance is related to vascular disease and diabetes in a family study of type 2 diabetes [abstract]. Diabetes.
2011;
60(Suppl 1):A225-A226.
Ramos PS, Oates JC, Kamen DL, Gaffney PM, Langefeld CD, Kelly JA, Kaufman KM, Kimberly RP, Niewold TB, Freedman BI, et al.
Association of reactive intermediate genes with systemic lupus erythematosus (SLE) varies across populations with differnet African ancestries [abstract]. Arthritis Rheum.
2011;
63(10 Suppl):S250.
Adrianto I, Wiley GB, Wang S, Kaufman KM, Anaya J-M, Alarcon-Riquelme ME, Bae S-C, Brown EE, Freedman BI, Langefeld CD, et al.
A functional haplotype in the region of TNIP1 is associated with systemic lupus erythematosus in multiple populations [abstract]. Arthritis Rheum.
2011;
63(10 Suppl):S248.
Wang S, Adrianto I, Wiley GB, Kaufman KM, Anaya J-M, Alarcon-Riquelme ME, Bae S-C, Brown EE, Freedman BI, Langefeld CD, et al.
A single risk haplotype in the region of UBE2L3 is associated with systemic lupus erythematosus in multiple ethnic populations [abstract]. Arthritis Rheum.
2011;
63(10 Suppl):S247-S248.
Kariuki S, Franek BS, Kumar AA, Kumabe M, Kaufman KM, Anaya J-M, Alarcon-Riquelme ME, Bae S-C, Freedman BI, Langefeld CD, et al.
Genetic associations with serologic autoimmunity in a large multi-ancestral systemic lupus erythematosus cohort [abstract]. Arthritis Rheum.
2011;
63(10 Suppl):S246.
Sanchez E, Nadig A, Richardson BC, Freedman BI, Kaufman K, Niewold TB, Kamen DL, Gilkeson GS, Langefeld CD, Kimberly RP, et al.
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus [abstract]. Arthritis Rheum.
2011;
63(10 Suppl):S245-S246.
Chung SA, Brown EE, Williams AH, Bhangale T, Ramos PS, Ziegler JT, Freedman BI, Kimberly RP, Vyse TJ, Langefeld CD, et al.
Lupus nephritis susceptibility markers in PDGRFA-GSX2, SLC5A11, ID4, and HAS2-SNTB1 regions identified from a meta-analysis of genome wide association studies of women with systemic lupus erythematosus [abstract]. Arthritis Rheum.
2011;
63(10 Suppl):S967.
Agarwal S, Cox AJ, Herrington DM, Morgan T, Xu J, Freedman BI, Carr JJ, Bowden DW.
Coronary artery calcium score and prediction of cardiovascular mortality in diabetes. Diabetes Heart Study [abstract]. In: Meeting Abstracts of the 71st Scientific Sessions; 2011 June 24-28; San Diego (CA).
2011;
():2-LB.
Hester J, Li J, Hicks P, Langefeld C, Freedman B, Bowden D, Ng M.
Implication of European-derived adiposity loci in African Americans [abstract]. In: Abstracts of the 61st Annual Meeting of the American Society of Human Genetics; 2011 Oct 11-15; Montreal (Canada).
2011;
():.
Price A, Zaitlen N, Lindstrom S, Pasaniuc B, Cornelis M, Genovese G, Bowden D, Freedman B, Hicks P, Langefeld C, et al.
Liability threshold modeling of covariates increases power in case-control association studies [abstract]. In: Abstracts of the 61st Annual Meeting of the American Society of Human Genetics; 2011 Oct 11-15; Montreal (Canada).
2011;
():.
Adams JN, Cox AJ, Freedman BI, Carr JJ, Bowden DW.
Effects of variation in the haptoglobin gene on subclinical cardiovascular disease in the Diabetes Heart Study [abstract]. In: Abstracts of the 61st Annual Meeting of the American Society of Human Genetics; 2011 Oct 11-15; Montreal (Canada).
2011;
():.
Oates J, Kamen D, Gaffney P, Langefeld C, Kelly J, Kaufman K, Kimberly R, Niewold T, Freedman B, Ramos P, et al.
Genetic risk factors associated with systemic lupus erythematosus (SLE) in reactive intermediate genes vary across African ancestries [abstract]. In: Abstracts of the 61st Annual Meeting of the American Society of Human Genetics; 2011 Oct 11-15; Montreal (Canada).
2011;
():.
Ng MCY, Sajuthi S, Cupples A, Divers J, Dupuis J, Fornage M, Kao L, Larkin E, Freedman B, Bowden DW, et al.
Genetic ancestry and population structure of geographically separated African American populations [abstract]. In: Abstracts of the 61st Annual Meeting of the American Society of Human Genetics; 2011 Oct 11-15; Montreal (Canada).
2011;
():.
Hellwege JN, Hicks PJ, Palmer ND, Freedman BI, Bowden DW.
Examination of rare variants in HNF4 alpha in European Americans with type 2 diabetes [abstract]. In: Abstracts of the 61st Annual Meeting of the American Society of Human Genetics; 2011 Oct 11-15; Montreal (Canada).
2011;
():.
Cooke J, Ng M, Lu L, Li J, An S, Hester J, Xu J, Freedman B, Langefeld C, Bowden D, Palmer N.
Genetic risk assessment of type 2 diabetes associated polymorphisms in African-Americans [abstract]. In: Abstracts of the 61st Annual Meeting of the American Society of Human Genetics; 2011 Oct 11-15; Montreal (Canada).
2011;
():.
Freedman BI, Langefeld CD, Murea M, Ma L, Otvos JD, Turner J, Antinozzi PA, Divers J, Hicks PJ, Bowden DW, Rocco MV, Parks JS.
Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans. Nephrol Dial Transplant.
2011;
26(11):3805-3810.
Sanchez E, Comeau ME, Freedman BI, Kelly JA, Kaufman K, Langefeld CD, Brown EE, Merrill JT, Tsao BP, Kamen DL, et al.
Identification of novel genetic susceptibility loci in African-American lupus patients using a candidate gene association study [abstract]. Arthritis Rheum.
2011;
63(10 Suppl):S965-S966.
Sanchez E, Comeau ME, Freedman BI, Kelly JA, Kaufman KM, Langefeld CD, Brown EE, Alarcon GS, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Vila LM, Merrill JT, Tsao BP, Kamen DL, Gilkeson GS, James JA, Vyse TJ, Gaffney PM,.
Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum.
2011;
63(11):3493-3501.
Rudock ME, Cox AJ, Ziegler JT, Lehtinen AB, Connelly JJ, Freedman BI, Carr JJ, Langefeld CD, Hauser ER, Horne BD, Bowden DW.
Cigarette smoking status has a modifying effect on the association between polymorphisms in KALRN and measures of cardiovascular risk in the Diabetes Heart Study. Genes Genomics.
2011;
33(5):483-490.
Agarwal S, Herrington DM, Cox AJ, Morgan TM, Xu J, Carr JJ, Freedman BI, Bowden DW.
The association of vascular calcification and all cause mortality in diabetes: Diabetes Heart Study [abstract]. Circulation.
2011;
124(21 Suppl):A8165.
Freedman BI, Shenoy RN, Planer JA, Clay KD, Shihabi ZK, Burkart JM, Sabio H, Byers JR, Russell GB, Bleyer AJ, et al.
Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Perit Dial Int.
2010;
30(1):72-79.
Maeda S, Kobayashi M-a, Araki S-i, Babazono T, Freedman BI, Bostrom MA, Cooke JN, Toyada M, Umezono T, Tarnow L, et al.
A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes. PLoS Genet.
2010;
6(2):e1000842.
Freedman BI, Wagenknecht LE, Hairston KG, Bowden DW, Carr JJ, Hightower RC, Gordon EJ, Xu J, Langefeld CD, Divers J.
Vitamin D, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab.
2010;
95(3):1076-1083.
Freedman BI, Shihabi ZK.
Variation in urinary myoinositol in renal disorders [abstract]. Ann Clin Lab Sci.
2010;
40(2):201.
Chen Y, Lipkowitz MS, Salem RM, Fung MM, Bhatnagar V, Mahata M, Nievergelt CM, Hicks PJ, Bowden DW, Freedman BI, et al.
Progression of chronic kidney disease: adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis. Am J Nephrol.
2010;
32(1):23-30.
Burdon KP, Rudock ME, Lehtinen AB, Langefeld CD, Bowden DW, Register TC, Liu Y, Freedman BI, Carr JJ, Hedrick CC, et al.
Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the Diabetes Heart Study. Mediators Inflamm.
2010;
2010():170153.
Bleyer AJ, Reddy SV, Sujata L, Russell GB, Akinnifesi D, Bleyer AJ Jr, Hire D, Shihabi Z, Knovich MA, Daeihagh P, Calles J, Freedman BI.
Sickle cell trait and development of microvascular complications in diabetes mellitus. Clin J Am Soc Nephrol.
2010;
5(6):1015-1020.
Freedman BI, Edberg JC, Comeau ME, Murea M, Bowden DW, Divers J, Alarcon GS, Brown EE, McGwin G Jr, Langefeld CD, et al.
The non-muscle myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans. Am J Nephrol.
2010;
32(1):66-72.
Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Hicks PJ, et al.
Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science.
2010;
329(5993):841-845.
Bleyer AJ, Vidya S, Sujata L, Russell GB, Akinnifesi D, Hire D, Shihabi Z, Knovich MA, Daeihagh P, Calles J, Freedman BI.
The impact of sickle cell trait on glycated haemoglobin in diabetes mellitus. Diabet Med.
2010;
27(9):1012-1016.
Reeves-Daniel A, Freedman BI, Assimos D, Hartmann EL, Bleyer A, Adams PL, Westcott C, Stratta RJ, Rogers J, Farney AC, Daniel KR.
Short-term renal outcomes in African American and Caucasian donors following live kidney donation. Clin Transplant.
2010;
24(5):717-722.
Tang SCW, Leung VTM, Chan LYY, Ma L, Elbein SC [deceased], Bowden DW, Hicks PJ, Comeau ME, Langefeld CD, Freedman BI, et al.
The acetyl-coenzyme A carboxylase beta (ACACB) gene is associated with nephropathy in Chinese patients with type 2 diabetes. Nephrol Dial Transplant.
2010;
25(12):3931-3934.
Bowden DW, Cox AJ, Freedman BI, Hugenschimdt CE [sic] [Hugenschmidt CE], Wagenknecht LE, Herrington D, Agarwal S, Register TC, Maldjian JA, Ng MC-Y, Hsu F-C, Langefeld CD, Williamson JD, Carr JJ.
Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications. Rev Diabet Stud.
2010;
7(3):188-201.
Mcdonough CW, Allred ND, Hicks PJ, Bostrom MA, Lu L, Ng M, Divers J, Langefeld CD, Freedman BI, Bowden DW.
A genome wide association study for diabetic nephropathy genes in African Americans [abstract]. J Am Soc Nephrol.
2010;
21(Suppl):729A.
Freedman BI, Langefeld CD, Lu L, Divers J, Comeau ME, Allred ND, Hicks PJ, Bostrom MA, Cooke JN, Mcdonough CW, Bowden DW, et al.
Accounting for risk variants in MYH9 reveals FRMD3 association with diabetic ESRD in African Americans [abstract]. J Am Soc Nephrol.
2010;
21(Suppl):728A.
Antinozzi PA, Barnes BC, Deegan D, Ma L, Freedman BI, Murea M.
Digital deconstruction of heterogeneous renal cell preparations with high-content imaging and cell specific biomarkers [abstract]. J Am Soc Nephrol.
2010;
21(Suppl):409A.
Bostrom MA, Lu L, Chou JW, Hicks PJ, Xu J, Langefeld CD, Bowden DW, Freedman BI.
Non-diabetic end-stage renal disease (ESRD) in African Americans: candidate genes from analysis of a pooled DNA-based genome wide association study (GWAS) [abstract]. J Am Soc Nephrol.
2010;
21(Suppl):89A.
Bostrom MA, Hicks PJ, Lu L, Ng M, Langefeld CD, Freedman BI, Bowden DW.
Sequencing of alpha-actinin-4 to identify variants associated with non-diabetic end-stage renal disease (ESRD) in African Americans [abstract]. J Am Soc Nephrol.
2010;
21(Suppl):729A.
Murea M, Lu L, Hicks PJ, Bowden DW, Divers J, Langefeld CD, Freedman BI.
Genetic variants identified by GWAS suggest intracellular calcium, vascular remodeling, and cardiac repolarization pathways impact dialytic survival in African Americans with diabetes [abstract]. J Am Soc Nephrol.
2010;
21(Suppl):730A.
Cooke JN, Bostrom MA, Hicks PJ, Ng M, Comeau ME, Divers J, Langefeld CD, Freedman BI, Bowden DW.
Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans [abstract]. J Am Soc Nephrol.
2010;
21(Suppl):731A.
Agarwal S, Morgan T, Herrington D, Xu J, Freedman BI, Carr JJ, Bowden DW.
Risk stratification in a diabetic population with metabolic syndrome using coronary calcium scores: Diabetes Heart Study [abstract]. Circulation.
2010;
122(21 Suppl):abstr 9342.
Freedman BI, Kopp JB, Winkler CA, Nelson GW, Rao DC, Eckfeldt JH, Leppert MF, Hicks PJ, Divers J, Langefeld CD, Hunt SC.
Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Am J Nephrol.
2009;
29(6):626-632.
Freedman BI, Hicks PJ, Bostrom MA, Cunningham ME, Liu Y, Divers J, Kopp JB, Winkler CA, Langefeld CD, Bowden DW, et al.
Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int.
2009;
75(7):736-745.
Leak TS, Perlegas PS, Smith SG, Keene KL, Hicks PJ, Langefeld CD, Mychaleckyj JC, Kirk JK, Freedman BI, Bowden DW, Sale MM, et al.
Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans. Ann Hum Genet.
2009;
73(2):152-159.
Freedman BI, Bowden DW, Rich SS.
Susceptibility to diabetic nephropathy. In: Lifton RP, Somlo S, Giebisch GH, Seldin DW, eds. Genetic diseases of the kidney.
Boston (MA): Elsevier/Academic Press;
2009:
771-792.
Iyengar SK, Freedman BI.
Chronic renal failure. In: Lang F, ed. Encyclopedia of molecular mechanisms of disease.
Berlin: Springer;
2009:
.
Shihabi ZK, Garrison KJ, Freedman BI.
Determination of urinary myo-inositol using the Beckman DXC 800 [abstract]. Clin Chem.
2009;
55(6 Suppl):A211.
Freedman BI, Nagaraj SK, Lin JJ, Gautreaux MD, Bowden DW, Iskandar SS, Stratta RJ, Rogers J, Hartmann EL, Farney AC, Reeves-Daniel AM.
Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation. Am J Transplant.
2009;
9(10):2435-2440.
Bowden DW, Allred NP, Ng MC, Langefeld CD, Freedman BI.
Genome wide analysis of African American type 2 diabetes [abstract]. Diabetologia.
2009;
52(Suppl 1):S37.
Malhotra A, Igo RP Jr, Thameem F, Kao WHL, Abboud HE, Adler SG, Arar NH, Bowden DW, Duggirala R, Freedman BI, et al.
Genome-wide linkage scans for type 2 diabetes mellitus in four ethnically diverse populations--significant evidence for linkage on chromosome 4q in African Americans: the Family Investigation of Nephropathy and Diabetes research group. Diabetes Metab Res Rev.
2009;
25(8):740-747.
Freedman BI, Hicks PJ, Bostrom MA, Comeau ME, Divers J, Bleyer AJ, Kopp JB, Winkler CA, Langefeld CD, Bowden DW, et al.
Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant.
2009;
24(11):3366-3371.
Bostrom MA, Lu L, Chou J, Hicks PJ, Xu J, Langefeld CD, Freedman BI, Bowden DW.
Genome wide association study of non-diabetic end stage renal disease in African Americans using pooled DNA [abstract]. Presented at the 59th Annual Meeting of The American Society of Human Genetics, October 21, 2009, Honolulu, Hawaii.
2009;
():A676.
Hester JM, Palmer ND, Ng MCY, Adeyemo A, Rotimi C, Freedman BI, Bowden DW.
Comprehensive genetic evaluation of variation at the TCF7L2 locus in African Americans [abstract]. Diabetes.
2009;
58(Suppl 1):A304.
Divers J, Wagenknecht LE, Bowden DW, Carr JJ, Hightower RC, Xu J, Langefeld CD, Freedman BI.
Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: African American-Diabetes Heart Study [abstract]. J Am Soc Nephrol.
2009;
20(Renal Week 2009 Abstract Issue):395A.
McDonough CW, Palmer ND, Bostrom MA, Hicks PJ, Lu L, Divers J, Langefeld CD, Freedman BI, Bowden DW.
A genome-wide association study (GWAS) of diabetic nephropathy (DN) in African Americans (AA) [abstract]. J Am Soc Nephrol.
2009;
20(Renal Week 2009 Abstract Issue):433A.
Freedman BI, Bostrom MA, Cooke JN, Divers J, Langefeld CD, Nelson RG, Kretzler M, Maeda S, Bowden DW.
ACACB gene associations with type 2 diabetes-associated ESRD [abstract]. J Am Soc Nephrol.
2009;
20(Renal Week 2009 Abstract Issue):55A.
Bostrom MA, Hicks PJ, Lu L, Langefeld CD, Bowden DW, Freedman BI.
Association of polymorphisms in the Klotho gene with age at onset of non-diabetic ESRD in African Americans [abstract]. J Am Soc Nephrol.
2009;
20(Renal Week 2009 Abstract Issue):431A.
Freedman BI, Hicks PJ, Bostrom MA, Comeau ME, Divers J, Bleyer AJ, Kopp JB, Winkler CA, Langefeld CD, Bowden DW, et al.
Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans (AA) with type 2 diabetes (T2DM)-associated ESRD [abstract]. J Am Soc Nephrol.
2009;
20(Renal Week 2009 Abstract Issue):431A.
Lipkowitz MS, Iyengar SK, Molineros J, Langefeld CD, Comeau ME, Klotman PE, Bowden DW, Freedman RG, Khitrov G, Freedman BI, et al.
Association analysis of the non-muscle myosin heavy chain 9 gene (MYH9) in hypertensive nephropathy: results from the African American Study of Kidney Disease and Hypertension (AASK) [abstract]. J Am Soc Nephrol.
2009;
20(Renal Week 2009 Abstract Issue):56A.
Freedman BI, Shihabi ZK, Andries L, Spainhour M, Byers JR, Russell GB, Stratta RJ, Calles J, Bleyer AJ.
Accuracy of the glycated albumin (GA) and hemoglobin (Hb) A1c assays in diabetic subjects with advanced chronic kidney disease (CKD) [abstract]. J Am Soc Nephrol.
2009;
20(Renal Week 2009 Abstract Issue):424A.
Bostrom MA, Lu L, Chou J, Hicks PJ, Xu J, Langefeld CD, Bowden DW, Freedman BI.
Candidate genes for non-diabetic end stage renal disease in African Americans identified by genome-wide association [abstract]. J Am Soc Nephrol.
2009;
20(Renal Week 2009 Abstract Issue):431A.
Winkler C, Nelson GW, Freedman BI, Bowden DW, Langefeld CD, Kopp JB.
MYH9 fine mapping refines region of association with chronic and end stage kidney diseases to introns 12 and 13 [abstract]. J Am Soc Nephrol.
2009;
20(Renal Week 2009 Abstract Issue):431A.
Carr JJ, Register TC, Hsu F-C, Lohman K, Lenchik L, Bowden DW, Langefeld CD, Xu J, Wagenknecht LE, Freedman BI, et al.
Calcified atherosclerotic plaque and bone mineral density in type 2 diabetes: the Diabetes Heart Study. Bone.
2008;
42(1):43-52.
Schelling JR, Abboud HE, Nicholas SB, Pahl MV, Sedor JR, Adler SG, Arar NH, Bowden DW, Freedman BI, Rich SS, et al.
Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigatin of Nephropathy and Diabetes (FIND). Diabetes.
2008;
57(1):235-243.
Salem RM, Cadman PE, Chen Y, Rao F, Wen G, Hamilton BA, Rana BK, Bowden DW, Hicks PJ, Freedman BI, et al.
Chromogranin A polymorphisms are associated with hypertensive renal disease. J Am Soc Nephrol.
2008;
19(3):600-614.
Horton GD, Freedman BI, Shihabi ZK.
Glycated albumin analysis on an automated analyzer [abstract]. Ann Clin Lab Sci.
2008;
38(2):188.
Vachharajani TJ, Moossavi S, Daeihgah P, Jordan JR, Coe MS, Burkart JM, Freedman B.
Academic free-standing vascular access centers: early experience [abstract]. Semin Dial.
2008;
21(1):106.
Vachharajani TJ, Moossavi S, Kaufman TM, Jordan JR, Freedman BI, Burkart JM.
Re-evaluating the fistula first initiative in octogenarian dialysis patients [abstract]. J Vasc Access.
2008;
9(Suppl 1):S16-S17.
Keene KL, Mychaleckyj JC, Smith SG, Leak TS, Perlegas PS, Langefeld CD, Herrington DM, Freedman BI, Bowden DW, Sale MM, et al.
Comprehensive evaluation of the estrogen receptor alpha gene reveals further evidence for association with type 2 diabetes enriched for nephropathy in an African American population. Hum Genet.
2008;
123(4):333-341.
Reeves-Daniel A, Daniel K, Assimos D, Westcott C, Rogers J, Farney A, Stratta R, Hartmann E, Adams P, Bleyer A, Freedman B.
Similar short-term renal outcomes among African Americans and caucasians following live kidney donation [abstract]. Am J Transplant.
2008;
8(Suppl 2):191.
Shihabi ZK, Horton GD, Freedman BI.
Glycated albumin analysis on the ADVIA 1650 [abstract]. Clin Chem.
2008;
54(6 Suppl):A173.
Liu Y, Freedman BI, Burdon KP, Langefeld CD, Howard T, Herrington D, Goff DC Jr, Bowden DW, Wagenknecht LE, Rich SS, et al.
Association of arachidonate 12-lipoxygenase genotype variation and glycemic control with albuminuria in type 2 diabetes. Am J Kidney Dis.
2008;
52(2):242-250.
Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Divers J, Freedman BI, et al.
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet.
2008;
40(10):1185-1192.
Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, Mckenzie LM, Kajiyama H, Ahuja TS, et al.
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet.
2008;
40(10):1175-1184.
Arar NH, Freedman BI, Adler SG, Iyengar SK, Chew EY, Davis MD, Satko SG, Bowden DW, Duggirala R, Elston RC, et al.
Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci.
2008;
49(9):3839-3845.
Bowden DW, Lewis JP, Allred ND, Langefeld CD, Divers J, Freedman BI.
Genetic analysis of 'European' type 2 diabetes SNPs from whole genome association studies in African Americans [abstract]. Diabetologia.
2008;
51(Suppl 1):S129.
Bowden DW, Lehtinen AB, Ziegler JT, Rudock ME, Xu J, Wagenknecht LE, Herrington DM, Rich SS, Freedman BI, Carr JJ, Langefeld CD.
Genetic epidemiology of subclinical cardiovascular disease in the Diabetes Heart Study. Ann Hum Genet.
2008;
72(Pt 5):598-610.
Freedman BI, Shenoy RN, Planer JA, Bleyer AJ, Cardona CY, Peacock TP, Andreis L, Byers JR, Russell GB, Shihabi ZK, et al.
Glycated albumin more accurately reflects glycaemic control than HbA(1c) in diabetic subjects on peritoneal and hemodialysis [abstract]. Diabetologia.
2008;
51(Suppl 1):S413-S414.
Bento JL, Palmer ND, Zhong M, Roh B, Lewis JP, Wing MR, Pandya H, Freedman BI, Langefeld CD, Bowden DW, et al.
Heterogeneity in gene loci associated with type 2 diabetes on human chromosome 20q13.1. Genomics.
2008;
92(4):226-234.
Kopp J, Smith M, Nelson G, Johnson R, Freedman B, Bowden D, Oleksyk T, McKenzie L, Kajiyama H, Ahuja T, et al.
Genome wide admixture mapping identifies MYH9 as a major effect risk gene for focal segmental glomerulosclerosis and hypertensive end-stage kidney disease [abstract]. J Am Soc Nephrol.
2008;
19():57A-58A.
Kao L, Klag M, Meoni L, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Divers J, Freedman B, et al.
Admixture scan identifies MYH9 locus to be associated with non-diabetic ESRD in African Americans [abstract]. J Am Soc Nephrol.
2008;
19():58A.
Freedman BI, Hicks PJ, Bostrom MA, Divers J, Winkler CA, Kopp JB, Nelson GW, Cunningham ME, Langefeld CD, Bowden DW.
Non-muscle myosin heavy chain 9 (MYH9) gene associations in African Americans (AA) with non-diabetic ESRD [abstract]. J Am Soc Nephrol.
2008;
19():132A.
McDonough CW, Hicks PJ, Freedman BI, Bowden DW.
Association of the carnosinase genes (CNDP1 and CNDP2) with diabetic nephropathy (DN) in African Americans (AA) [abstract]. J Am Soc Nephrol.
2008;
19():132A.
Freedman BI, Edberg C, Kopp JB, Winkler CA, Nelson GW, Alarcon GS, Brown EE, Divers J, Cunningham ME, Langefeld CD, et al.
Association analysis of the non-muscle myosin heavy chain 9 (MYH9) gene in African Americans with lupus nephritis (LN) [abstract]. J Am Soc Nephrol.
2008;
19():134A.
Freedman BI, Kopp JB, Winkler CA, Nelson GW, Rao DC, Eckfeldt JH, Leppert MF, Hunt SC.
MYH9 variants are associated with albuminuria in HyperGEN families [abstract]. J Am Soc Nephrol.
2008;
19():135A.
Thomas RL, Bleyer A, Kretzler M, Freedman BI, Iyengar SK, Schelling JR, Sedor JR.
African American and European American diabetic sibs with normal GFR and family history of diabetic nephropathy (DN) lose GFR at equivalent rates but faster than diabetic subjects with no family history [abstract]. J Am Soc Nephrol.
2008;
19():335A-336A.
Song EY, McClellan WM, McClellan A, Gadi R, Krisher J, Clay M, Freedman BI.
The effect of neighborhood characteristics on family history (FH) of ESRD [abstract]. J Am Soc Nephrol.
2008;
19():499A-500A.
Louvar D, Li N, Eckfeldt J, Gu C, Freedman B, Pankow J.
Angiotensinogen as a candidate gene for albuminuria, glomerular filtration rate, and systolic blood pressure [abstract]. J Am Soc Nephrol.
2008;
19():826A.
Moossavi S, Russell G, Vachharajani T, Burkart J, Freedman B.
Effect of practice pattern on hemodialysis access thrombosis: the impact of access surveillance [abstract]. J Am Soc Nephrol.
2008;
19():901A.
Planer JA, Bleyer AJ, Shenoy RN, Clay KD, Cardona CY, Sabio H, Russell GB, Shihabi ZK, Freedman BI.
Ethnic variation in hemoglobin (Hb) A1c and glycated albumin (GA) assays in patients on hemodialysis (HD) [abstract]. J Am Soc Nephrol.
2008;
19():974A.
Shenoy RN, Planer JA, Clay KD, Bleyer AJ, Burkart JM, Cardona CY, Byers JR, Russell GB, Shihabi ZK, Freedman BI, et al.
Evaluation of glycated albumin (GA), HbA1c and serum glucose concentrations in diabetic peritoneal (PD) and hemodialysis (HD) patients [abstract]. J Am Soc Nephrol.
2008;
19():974A-975A.
North KE, Franceschini N, Borecki IB, Gu CC, Heiss G, Province MA, Arnett DK, Lewis CE, Miller MB, Freedman BI, et al.
Genotype-by-sex interaction on fasting insulin concentration: the HyperGEN Study. Diabetes.
2007;
56(1):137-142.
Gallagher CJ, Keene KL, Mychaleckyj JC, Langefeld CD, Hirschhorn JN, Gordon CJ, Freedman BI, Rich SS, Bowden DW, Sale MM, et al.
Investigation of the estrogen receptor-alpha gene with type 2 diabetes and/or nephropathy in African-American and European-American populations. Diabetes.
2007;
56(3):675-684.
Freedman BI, Hicks PJ, Sale MM, Pierson ED, Langefeld CD, Rich SS, Xu J, McDonough C, Janssen B, Bowden DW, et al.
A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. Nephrol Dial Transplant.
2007;
22(4):1131-1135.
North KE, Chung J, Baird L, Avery C, Freedman BI, Kraja AT, Arnett D, Miller MB, Pankow JS, et al.
Evidence for association between CHEK2 variants and type 2 diabetes: the HyperGEN study [abstract]. Circulation.
2007;
115(8):e293-e294.
Yosipovitch G, Hicks MI, Freedman BI, Guzman-Sanchez DA, Ishiuji Y, Patel T, Chan YH, Crumrine D, Elias PM.
The structure of the skin barrier and its relationship to pruritus in end-stage renal disease [abstract]. J Invest Dermatol.
2007;
127(Suppl 1):S72.
Iyengar SK, Abboud HE, Goddard KAB, Saad MF, Adler SG, Arar NH, Bowden DW, Duggirala R, Rich SS, Freedman BI, et al.
Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations. Diabetes.
2007;
56(6):1577-1585.
Sedro JR, Abboud HE, Freedman BI, et al.
A genome-wide scan for estimated glomerular filtration rate (eGFR): the Family Investigation of Nephropathy and Diabetes (FIND) Study [abstract]. J Am Soc Nephrol.
2007;
18(Abstracts Issue):14A.
Leak TS, Perlegas PS, Smith SG, Hicks PJ, Li L, Langefeld CD, Keene KL, Sale MM, Freedman BI, Bowden DW.
Variants in the ELMO1 gene are associated with diabetes and nephropathy in African Americans [abstract]. J Am Soc Nephrol.
2007;
18(Abstracts Issue):14A.
Salem RM, Cadman PE, Chen Y, Taupenot L, Rao F, Wen G, Hamilton BA, Bowden DW, Hicks PJ, Freedman BI, et al.
Polymorphisms at the catecholamine storage vesicle biosynthetic locus chromogranin A are risk factors for hypertensive end stage renal disease [abstract]. J Am Soc Nephrol.
2007;
18(Abstracts Issue):15A-16A.
Schelling JR, Bleyer AJ, Freedman BI, Sedor JR.
Diabetic sibs with normal GFR and family history of diabetic nephropathy (DN) develop progressive nephropathy: a risk group for targeted intervention [abstract]. J Am Soc Nephrol.
2007;
18(Abstracts Issue):571A.
Bostrom MA, Sale MM, Leak TS, Freedman BI, Bowden DW.
Insulin-like growth factor binding protein 1 and 3 gene associations in African Americans with type 2 diabetic end stage renal disease [abstract]. J Am Soc Nephrol.
2007;
18(Abstracts Issue):606A.
McDonough CW, Hicks PJ, Freedman BI, Bowden DW.
Genetic evaluation of CNDP1 and CNDP2 polymorphisms in diabetic nephropathy [abstract]. J Am Soc Nephrol.
2007;
18(Abstracts Issue):607A.
Adler S, Chew E, Freedman BI, et al.
Coincident linkage peaks for nephropathy and retinopathy: the Family Investigation of Nephropathy and Diabetes (FIND) Study [abstract]. J Am Soc Nephrol.
2007;
18(Abstracts Issue):607A.
Nelson RG, Nicholas SB, Freedman BI, et al.
A search for diabetes genes in four ethnic groups selected for diabetic nephropathy: the Family Investigation of Nephropathy and Diabetes (FIND) Study [abstract]. J Am Soc Nephrol.
2007;
18(Abstracts Issue):607A.
Iyengar SK, Freedman BI, et al.
A multi-ethnic genome-wide linkage study for diabetic nephropathy. The Family Investigation of Nephropathy and Diabetes (FIND) Study [abstract]. J Am Soc Nephrol.
2007;
18(Abstracts Issue):608A.
Parekh RS, Freedman BI, Bowden DW, Satko SC [sic] [Satko SG], Rich SS, Warren S, Viverette S, Brooks G, Young R, Spainhour M, et al.
Reliability of urinary albumin, total protein, and creatinine assays after prolonged storage: the Family Investigation of Nephropathy and Diabetes. Clin J Am Soc Nephrol.
2007;
2(6):1156-1162.
Lehtinen AB, Newton-Cheh C, Ziegler JT, Langefeld CD, Freedman BI, Daniel KR, Herrington DM, Bowden DW.
Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study [abstract]. Circulation.
2007;
116(16 Suppl):652-653.
Bowden DW, Rudock M, Ziegler J, Lehtinen AB, Xu J, Wagenknecht LE, Herrington D, Rich SS, Freedman BI, Carr JJ, Langefeld CD.
Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the Diabetes Heart Study. Diabetes.
2006;
55(7):1985-1994.
Leak TS, Mychaleckyj JC, Keene KL. Gordon CJ, Hicks PJ, Freedman BI, Bowden DW, Sale MM.
A dense SNP map of human chromosome 6q24-27 to localize a type 2 diabetes gene in an African American population [abstract]. Diabetes.
2006;
55(Suppl 1):A261.
Keene KL, Gallagher CJ, Mychaleckyj JC, Langefeld CD, Hirschhorn JN, Henderson BE, Freedman BI, Rich SS, Bowden DW, Sale MM, et al.
Association of the estrogen receptor alpha gene with type 2 diabetes in African American and European American populations [abstract]. Diabetes.
2006;
55(Suppl 1):A260.
Bowden DW, Lehtinen AB, Ziegler JT, Herrington D, Wagenknecht LE, Rich SS, Freedman BI, Carr JJ, Langefeld CD.
A genome scan for subclinical cardiovascular disease in the Diabetes Heart Study [abstract]. Atheroscler Suppl.
2006;
7(3):89.
Avery CL, Freedman BI, Kraja AT, Borecki IB, Miller MB, Pankow JS, Arnett D, Lewis CE, Myers RH, Hung SC, et al.
Genotype-by-sex interaction in the aetiology of type 2 diabetes mellitus: support for sex-specific quantitative trait loci in Hypertension Genetic Epidemiology Network participants. Diabetologia.
2006;
49(10):2329-2336.
Rich SS, Burdon KP, Langefeld CD, Liu Y, Freedman BI, Carr JJ, Hedrick CC, Bowden DW.
Human lipoxygenase gene variation in subclinical atherosclerosis: the Diabetes Heart Study [abstract]. Atheroscler Suppl.
2006;
7(3):335.
Freedman BI, Hsu FC, Lohman K, Bowden DW, Leonchik L [sic] [Lenchik L], Langefeld CD, Xu J, Register Tc, Rich SS, Wagenknecht LE.
The relationship between calcified atherosclerotic plaque and bone mineral density: the Diabetes Heart Study [abstract]. Atheroscler Suppl.
2006;
7(3):14.
Lange LA, Burdon K, Langefeld CD, Liu Y, Beck SR, Rich SS, Freedman BI, Brosnihan KB, Herrington DM, Wagenknecht LE, Bowden DW.
Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study. Ann Hum Genet.
2006;
70(Pt 6):717-725.
Bleyer AJ, Sedor JR, Freedman BI, Schelling JR.
Screening diabetic siblings of diabetic end-stage kidney disease patients reveals frequent uncontrolled hypertension, uncontrolled diabetes, and albuminuria [abstract]. J Am Soc Nephrol.
2006;
17(Abstr Issue):82A.
Freedman BI, Bowden DW, Rich SS, Wagenknecht LE, Ziegler J, Sale MM, Langefeld CD.
Genome scans for glomerular filtration rate (GFR) and albuminuria: the Diabetes Heart Study (DHS) [abstract]. J Am Soc Nephrol.
2006;
17(Abstr Issue):84A.
Hicks PJ, Staten JL, Sale MM, Bowden DW, Freedman BI.
The ephrin-B2 gene is not associated with end-stage renal disease (ESRD) in African Americans (AA) [abstract]. J Am Soc Nephrol.
2006;
17(Abstr Issue):148A.
Freedman BI, Hicks PJ, Sale MM, Pierson ED, Langefeld CD, Rich SS, Janssen B, Yard BA, van der Woude FJ.
A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic nephropathy (DN) in European Americans (EA) [abstract]. J Am Soc Nephrol.
2006;
17(Abstr Issue):391A.
Freedman BI, Tuttle AB, Plonk GW, Bettmann MA, Majekodunmi O, Russell GB, Regan JD.
Long-term outcomes of transposed basilic vein arterio-venous fistulae (TBAVF) [abstract]. J Am Soc Nephrol.
2006;
17(Abstr Issue):497A.
Moossavi S, Regan JD, Pierson ED, Kasey JM, Tuttle AB, Bettmann MA, Russell GB, Freedman BI.
Non-surgical salvage of thrombosed arterio-venous fistulae (AVF) [abstract]. J Am Soc Nephrol.
2006;
17(Abstr Issue):500A.
Schelling JR, Sedor JR, Freedman BI, Rich SS, Iyengar SK, Bleyer AJ.
The Family Investigation of Nephropathy and Diabetes (FIND) longitudinal follow-up study: design and preliminary results [abstract]. J Am Soc Nephrol.
2006;
17(Abstr Issue):707A.
Saran A, Carr JJ, Lohman KK, Hsu F-C, Bowden DW, Freedman BI.
Renal volume (RV) is associated with sub-clinical atherosclerosis in type 2 diabetes: the Diabetes Heart Study (DHS) [abstract]. J Am Soc Nephrol.
2006;
17(Abstr Issue):584A.
All Publications
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.